Press "Enter" to skip to content

Aytu BioPharma, the Developer of Healight UVA Endotracheal Catheter, to Report Fourth Quarter and Fiscal 2022 Financial Results on Sept. 27, 2022

At AP News, Aytu BioPharma, Inc., a pharmaceutical company focused on commercializing novel therapeutics, with a development pipeline addressing rare, pediatric-onset disorders, will report financial…
This content is viewable by members only. Visit MY ACCOUNT on the top menu to log in or to register for a 30 day free trial or purchase a subscription for UV Reporter 1 Year Single Membership or UV Reporter 1 Year Group Membership - $89 for first member and $25 for each additional member.